20 Aug 2026Open access
Incidental diagnosis of an accessory ovary during cesarean section: a case report and literature reviewPublisher siteInternational Journal of Surgery Case Reports, Ovarian cancer diagnosis and treatment
Active, last published 2026
In ovarian cancer diagnosis and treatment
Brian Abraham
Muro
Scholar“Research focused on Ovarian cancer diagnosis and treatment and adjacent fields.”
Claim Your Profile0
H-index
0
Citations
Brian has not officially claimed their profile. If you are Brian, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
rian Abraham Muro is a researcher working on Ovarian cancer diagnosis and treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Brian's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Ovarian cancer diagnosis and treatment×1
04 · Where I am
Affiliations
Affiliation on published researchMuhimbili University of Health and Allied Sciences, TanzaniaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works16 Jun 2026Open access
Does Time to Surgery Matter? Clinical Severity Vs System Delay as Predictors of Maternal Death in Surgically Managed PPH at Muhimbili National Hospital in TanzaniaPublisher siteResearch Square, Maternal and fetal healthcare
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Brian?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you